4/15
04:02 pm
adap
Adaptimmune (ADAP) Down on End of Collaboration With Roche [Yahoo! Finance]
Medium
Report
Adaptimmune (ADAP) Down on End of Collaboration With Roche [Yahoo! Finance]
4/12
08:57 am
adap
Adaptimmune falls as Roche strategic collaboration ends [Seeking Alpha]
Medium
Report
Adaptimmune falls as Roche strategic collaboration ends [Seeking Alpha]
4/12
08:14 am
adap
Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated [Yahoo! Finance]
Medium
Report
Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated [Yahoo! Finance]
3/27
07:35 pm
adap
Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet [Yahoo! Finance]
Neutral
Report
Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet [Yahoo! Finance]
3/8
05:32 am
adap
Adaptimmune Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Low
Report
Adaptimmune Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
3/7
01:53 pm
adap
Adaptimmune Therapeutics PLC Reports Q4 and Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Adaptimmune Therapeutics PLC Reports Q4 and Full Year 2023 Financial Results [Yahoo! Finance]
3/7
08:41 am
adap
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/6
07:12 am
adap
Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates [Yahoo! Finance]
High
Report
Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates [Yahoo! Finance]
2/27
08:17 am
adap
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise [Yahoo! Finance]
Medium
Report
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise [Yahoo! Finance]
2/13
07:25 pm
adap
Adaptimmune Therapeutics PLC (ADAP) Stock Moves -1.24%: What You Should Know [Yahoo! Finance]
Low
Report
Adaptimmune Therapeutics PLC (ADAP) Stock Moves -1.24%: What You Should Know [Yahoo! Finance]
1/31
05:07 pm
adap
Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review [Yahoo! Finance]
Medium
Report
Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review [Yahoo! Finance]
1/30
01:13 pm
adap
Baillie Gifford Increases Stake in Adaptimmune Therapeutics PLC [Yahoo! Finance]
High
Report
Baillie Gifford Increases Stake in Adaptimmune Therapeutics PLC [Yahoo! Finance]
1/22
11:55 am
adap
Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer [Yahoo! Finance]
Low
Report
Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer [Yahoo! Finance]